News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
204 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44431)
2016 (38329)
2017 (37186)
2018 (39119)
2019 (51334)
2020 (57662)
2021 (58720)
2022 (53927)
2023 (42564)
2024 (37440)
2025 (33091)
2026 (28672)
Month
January (2488)
February (2603)
March (3227)
April (2950)
May (3962)
June (3500)
July (2854)
August (3141)
September (3204)
October (3539)
November (3386)
December (2332)
Day
2 (186)
3 (175)
4 (147)
5 (166)
6 (119)
9 (121)
10 (183)
11 (172)
12 (142)
13 (112)
14 (38)
15 (1)
16 (171)
17 (154)
18 (148)
19 (149)
20 (92)
21 (2)
23 (153)
24 (148)
25 (215)
26 (204)
27 (119)
28 (2)
29 (9)
30 (193)
31 (218)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
2
3
4
5
6
9
10
11
12
13
14
15
16
17
18
19
20
21
23
24
25
26
27
28
29
30
31
Genetown
Idera Pharmaceuticals Announces Pricing of Public Offering of Common Stock
The Company has granted the underwriters a 30-day option to purchase up to an additional 5,000,000 shares of common stock
October 26, 2017
·
4 min read
Business
ProQR Announces Management Change and Key Promotions
The company’s CMO will leave, effective November 4, 2017 to pursue a new opportunity.
October 26, 2017
·
6 min read
Business
Apricus Biosciences Announces Corporate Update and Third Quarter 2017 Financial Results Conference Call
Company management will host a conference call to discuss financial results and other recent corporate highlights.
October 26, 2017
·
1 min read
Deals
Analytical Lab Group Announces Acquisition and Appointment of Chief Executive Officer
Analytical Lab Group has recently completed an expansion of its laboratories by acquiring Microbiology & Quality Associates in the San-Francisco Bay area.
October 26, 2017
·
3 min read
Drug Development
Saniona Decides to Perform Interim Analysis of Tesomet Study in Patients With Prader-Willi Syndrome
Nine out of a planned ten adult patients with Prader-Willi syndrome have completed or discontinued from the Phase 2 study.
October 26, 2017
·
2 min read
Business
Loxo Oncology to Announce Third Quarter 2017 Financial Results and Host Conference Call
Loxo Oncology management will host a conference call to discuss these financial results, in addition to recent updates on development and corporate activities.
October 26, 2017
·
1 min read
Business
Recordati: Very Good Results In The First Nine Months 2017. Continued Growth In Sales +11.8%, Operating Income +21.8%, Net Income +20.6%. Interim Dividend € 0.42 (+20%)
These financial statements will be available today at the company’s offices and on the company’s website.
October 26, 2017
·
12 min read
Business
Integra LifeSciences Reports Third Quarter 2017 Financial Results
Total revenues for the third quarter were $278.8 million, reflecting an increase of $28.5 million, or 11.4%, over the third quarter of 2016.
October 26, 2017
·
21 min read
Drug Development
MediciNova Announces Positive Top-Line Results from the SPRINT-MS Phase IIb Trial of MN-166 (ibudilast) in Progressive MS: Achieved Both Primary Endpoints including a Significant Reduction in Whole Brain Atrophy and Safety and Tolerability
The study was conducted by the NeuroNEXT network with funding from the NIH National Institute of Neurological Diseases and Stroke, the National Multiple Sclerosis Society, and MediciNova.
October 26, 2017
·
9 min read
Business
Sonoma Pharmaceuticals Announces Fiscal Second Quarter 2018 Financial Results and Conference Call
The earnings release will be followed by a conference call at 1:30 p.m. PST on November 9, 2017, to discuss fiscal second quarter results.
October 26, 2017
·
1 min read
Previous
12 of 21
Next